EUVIMEDEUVIMED entdecken
Crossref

Effect of semaglutide on measured versus estimated glomerular filtration rate

Rafal Yahya, Esben Iversen iD, Suvanjaa Sivalingam, Louise Westberg Strejby Christensen, Frederik Persson iD, Tine W Hansen, Mads Hornum iD, Peter Rossing iD, Viktor R Curovic iD, Morten B Houlind iD

Nephrology Dialysis Transplantation · 03.07.2026

DOI: 10.1093/ndt/gfag154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 03.07.2026. Verfasst von Rafal Yahya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis Semaglutide is a glucagonlike peptide-1 receptor agonist widely used for its glucose-lowering effects in people with type 2 diabetes (T2D), as well as its cardiovascular and kidney-protective properties. However, it remains unclear whether semaglutide influences blood concentrations of endogenous filtration markers like creatinine, cystatin C, beta-trace protein (BTP), and beta-2 microglobulin (B2M). We investigated the effect of semaglutide on these filtration markers and the performance of estimated glomerular filtration rate (eGFR) equations compared with measured glomerular filtration rate (mGFR).

Methods

Post hoc analysis of a randomized, double-blind, placebo-controlled clinical trial. Individuals with T2D and albuminuria were randomized in a 1:1 ratio to receive semaglutide 1 mg weekly or matching placebo for 26 weeks on top of empagliflozin. mGFR was determined by technetium-99m diethylenetriaminepentaacetic acid (99m-Tc-DTPA) plasma clearance, and eGFR was calculated using CKD-EPI equations based on plasma creatinine (eGFRcre), cystatin C (eGFRcys), their combination (eGFRcomb), or a panel of creatinine, cystatin C, BTP, and B2M (eGFRpanel). Outcomes included change in filtration marker concentration, mGFR, and eGFR from baseline to end of treatment, as well as eGFR performance compared to mGFR at each time point.

Results

Among 48 participants (median age 70 years; 16.7% female), semaglutide treatment was associated with a small but significant increase in plasma creatinine and BTP compared with placebo, whereas there was no significant change in cystatin C or B2M. Semaglutide treatment was not associated with a significant change in mGFR [median (interquartile range (IQR)) change of 0 (−7.5 to 10.3) ml/min/1.73 m2] compared with placebo [median (IQR) change of -2 (−11.3 to 3.0) ml/min/1.73 m2]. Both eGFRcre and eGFRcys were consistently outperformed by eGFRcomb and eGFRpanel at baseline and end of treatment.

Conclusion

Semaglutide treatment was associated with a small increase in plasma creatinine and BTP but not cystatin C or B2M, and eGFRcomb yielded the most reliable estimates of mGFR.

Schlagwörter

Stichwörter der Autor:innen

estimated glomerular filtration ratefiltration markermeasured glomerular filtration ratesemaglutidetype 2 diabetes

Autor:innen und Institutionen

  • Department of Clinical Research, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.
  • Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
  • Department of Nephrology and Endocrinology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

ORCID-Profile: Esben Iversen, Frederik Persson, Mads Hornum, Peter Rossing, Viktor R Curovic, Morten B Houlind

Zitieren

APA

Yahya, R., Iversen, E., Sivalingam, S., Christensen, L. W. S., Persson, F., Hansen, T. W., Hornum, M., Rossing, P., Curovic, V. R., & Houlind, M. B. (2026). Effect of semaglutide on measured versus estimated glomerular filtration rate. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag154

Vancouver

Yahya R, Iversen E, Sivalingam S, Christensen LWS, Persson F, Hansen TW, et al. Effect of semaglutide on measured versus estimated glomerular filtration rate. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag154

BibTeX
@article{Yahya2026,
  author = {Yahya, Rafal and Iversen, Esben and Sivalingam, Suvanjaa and Christensen, Louise Westberg Strejby and Persson, Frederik and Hansen, Tine W and Hornum, Mads and Rossing, Peter and Curovic, Viktor R and Houlind, Morten B},
  title = {Effect of semaglutide on measured versus estimated glomerular filtration rate},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfag154}
}
Kostenlos starten →